2 employees
Myomar Molecular is developing a diagnostic tool to identify early stages of muscle atrophy.
2021
$2.5K
from 2 investors over 2 rounds
Myomar Molecular raised undisclosed on August 22, 2023
Investors: Startupfest
Myomar Molecular raised $2.5K on June 5, 2022
Investors: Bounce Health Innovation